prev
next
Latest Expert Opinions

General MM,Patients eligible for transplant,Patients non-eligible for transplant,Relapsed/refractory patients
Following NICE guidelines | An interview with Ceri Bygrave
Mar 29, 2018
Latest Drug Updates

Patients non-eligible for transplant
Daratumumab (darzalex) granted Priority Review as a frontline regimen